1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. Microbix Biosystems Acquires ImaRx Therapeutics - Urokinase

M&A Deal Summary

Microbix Biosystems Acquires ImaRx Therapeutics - Urokinase

On September 24, 2008, Microbix Biosystems acquired life science company ImaRx Therapeutics - Urokinase from ImaRx Therapeutics

Acquisition Highlights
  • This is Microbix Biosystems’ 1st transaction in the Life Science sector.
  • This is Microbix Biosystems’ 1st transaction in the United States.

M&A Deal Summary
Date 2008-09-24
Target ImaRx Therapeutics - Urokinase
Sector Life Science
Buyer(s) Microbix Biosystems
Sellers(s) ImaRx Therapeutics
Deal Type Divestiture

Target

ImaRx Therapeutics - Urokinase

United States
ImaRx Therapeutics - Urokinase is a thrombolytic or clot-dissolving agent indicated for the treatment of acute massive pulmonary embolism, or blood clots in the lungs.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Microbix Biosystems

Mississauga, Ontario, Canada
Category Company
Founded 1988
Sector Life Science
DESCRIPTION

Microbix Biosystems, Inc. is a provider of pharmaceutical services.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: United States M&A 1 of 1
Year: 2008 M&A 1 of 1

Seller(S) 1

SELLER

ImaRx Therapeutics

Redmond, Washington, United States
Category Company
Founded 1999
Sector Life Science
DESCRIPTION

ImaRx Therapeutics, Inc. is a biopharmaceutical company that has been focused on the research, development and commercialization of therapies for vascular disorders.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: United States M&A 1 of 1
Year: 2008 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal